Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan DeWolf

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cancer Discovery|April 30, 2026
Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute LeukemiasTakeshi Fujino, Jennifer Lewis, Bingyi Chen, et al.
Science Translational Medicine|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCTHana Andrlová, Oriana Miltiadous, Anastasia I Kousa, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplantSteven J Siegel, Susan DeWolf, Joseph Schmalz, et al.
Cancer Discovery|December 4, 2025
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC ModelUrvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, et al.
Research Square|February 10, 2021
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Discovery|April 30, 2026
Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute LeukemiasTakeshi Fujino, Jennifer Lewis, Bingyi Chen, et al.
Science Translational Medicine|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCTHana Andrlová, Oriana Miltiadous, Anastasia I Kousa, et al.
Science Translational Medicine|July 26, 2023
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouseSusan DeWolf, Yuval Elhanati, Katherine Nichols, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplantSteven J Siegel, Susan DeWolf, Joseph Schmalz, et al.
Cancer Discovery|December 4, 2025
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders - Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC ModelUrvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garces, et al.
Research Square|February 10, 2021
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Nature Medicine|May 21, 2021
CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.
Pageof 5